Own experience with labetalol - a new adrenergic alpha and beta receptor blockader - in the treatment of arterial hypertension
Cybulska, I.; Sznajderman, M.; Brym, E.; Czerniewska, E.
Polski Tygodnik Lekarski 36(34): 1309-1311
1981
ISSN/ISBN: 0032-3756 PMID: 7038638 Document Number: 177471
Document emailed within 1 workday
Related Documents
Zonis, B.Ia.; Brin, V.B. 1979: Changes of cardio- and hemodynamics during treatment of arterial hypertension with adrenergic alpha receptor blockader pyrroxane Terapevticheskii Arkhiv 51(11): 28-30Savenkov, P.M.; Doshitsin, V.L.; Grudtsyn, G.V. 1977: Use of the adrenergic beta receptor blockader, visken, (prindolol) in arterial hypertension Kardiologiia 17(10): 62-66
Shmidt, I.; Khomut, V.; Monike, V.; Bakh, K.; Fliugel', K. 1985: Central and peripheral hemodynamics during combined treatment of arterial hypertension with calcium antagonist nifedipine and beta-adrenergic blockader talinolol Kardiologiia 25(6): 110-111
Forette, F.; Henry-Amar, M.; d'Allens, H.; Hervy, M.P.; Bouchacourt, P.; Henry, J.F.; Pappo, M. 1987: Arterial hypertension in the elderly. Double-blind study versus placebo of the efficacy and tolerability of an alpha-beta blocker: labetalol Annales de Cardiologie et d'Angeiologie 36(2): 103-107
Leshchinskiĭ, L.A.; Logacheva, I.V.; Nikolaeva, V.A.; Plastinina, R.A.; Polischuk, M.A. 1983: Effect of the combined administration of alpha- and beta-adrenergic blockaders (propranolol and phentolamine) on central and renal hemodynamics during the treatment of patients with arterial hypertension Terapevticheskii Arkhiv 55(9): 48-51
Zilenovski, A.M.; Freire, C.A.; Iverson, M.T. 1984: Evaluation of the therapeutic efficacy of a fixed combination of beta blockader and diuretic, in the treatment of systemic arterial hypertension. a multicenter study Arquivos Brasileiros de Cardiologia 42(6): 435-441
Renouard, A.; Widdowson, P.S.; Millan, M.J. 1994: Multiple alpha 2 adrenergic receptor subtypes. I. Comparison of [3H]RX821002-labeled rat R alpha-2A adrenergic receptors in cerebral cortex to human H alpha2A adrenergic receptor and other populations of alpha-2 adrenergic subtypes Journal of Pharmacology and Experimental Therapeutics 270(3): 946-957
Takenaka, F.; Ishihara, T.; Maruyama, Y.; Matsumoto, S.; Inoue, H. 1974: Effects of an adrenergic beta-receptor blockader, 2-acetyl-7-(2-hydroxy-3-isopropylamino) propoxybenzofuran hydrochloride on the cardiovascular system Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 70(3): 385-397
De Petra, V.; Di Michele, R.; Cecchetti, E. 1973: Effects of an adrenergic beta receptor blockader on exercise tolerance and myocardial function in patients with angina pectoris Minerva Cardioangiologica 21(9): 619-624
Erina, E.V.; Basishvili, N.Z. 1978: Use of beta-adrenergic blockaders in the treatment of arterial hypertension Kardiologiia 18(3): 28-35
Bühler, F.R.; Lütold, B.E. 1976: Beta adrenergic receptor blockade as a basis for the treatment of hypertension Therapeutische Umschau. Revue Therapeutique 33(5): 336-346
Lydtin, H. 1975: The significance of beta-adrenergic receptor blocking agents in the treatment of hypertension Die Medizinische Welt 6(35): 1487-1492
Rasmussen, S.; Andreasen, P.B. 1980: Labetalol (Trandate). an antihypertensive agent with both alpha and beta receptor blockading effects Ugeskrift for Laeger 142(13): 839-841
Pir'ova, B. 1987: Alpha-adrenergic control of kidney function. its significance for the pathogenesis and treatment of arterial hypertension Vutreshni Bolesti 26(6): 12-18
Komissarenko, I.A. 2002: Treatment arterial hypertension by beta-adrenergic blockers in elderly patients with gastrointestinal disorders Eksperimental'naia i Klinicheskaia Gastroenterologiia 4: 18-20; 130
Vágfalvy, I.; Fehér, L. 1970: The use of iproveratril (a beta receptor blockader) in the treatment of thyrotixic crisis Orvosi Hetilap 111(12): 685-687
Metelitsa, V.I.; Filatova, N.P. 1990: Role of a beta adrenergic blocking agent nadolol (corgard) in prevention of arterial hypertension: a 6-month treatment (cooperative study) Kardiologiia 30(5): 8-14
Bonavita, E. 1984: Combined labetalol plus flunarizine treatment for arterial hypertension International Journal of Clinical Pharmacology Research 4(6): 475-480
Benchimol, A.B.; Sbissa, A.S.; Benchimol, C.B.; Saad, E.A.; Barbosa, E.T.; Albanesi Filho, F.M.; Pillegi, F.; da Cunha, G.P.; Maranhão, M.F.; Batlouni, M.; Schlesinger, P.; Duprat, R.; Maciel, R. 1982: Labetalol in the treatment of arterial hypertension. a Brazilian multicenter study Arquivos Brasileiros de Cardiologia 38(5): 421-427
Friedemann, M. 1975: Treatment of rhythm disorders following acute heart infarction using a beta receptor blockader (Visken) Schweizerische Medizinische Wochenschrift 105(30): 957-961